Acquiring Company
Bristol Myers Squibb
Acquired Company
Celgene
LawrencevilleOhioManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Bristol Myers Squibb completed its acquisition of Celgene in 2019 for $74 billion, marking a significant expansion into the neuroscience space. The merger has allowed BMS to enhance its pipeline for treating neuropsychiatric diseases, including multiple sclerosis and Alzheimer's. This strategic move is considered a foundational step in BMS's return to neuroscience after stepping away from it in 2013.
Don't miss Bristol Myers Squibb's next move
Get an email the moment Bristol Myers Squibb makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Celgene?
Celgene was acquired by Bristol Myers Squibb, based in Lawrenceville. The deal was reported on August 31, 2026. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol Myers Squibb is publicly traded (BMY) and operates in Manufacturing.
When did Bristol Myers Squibb acquire Celgene?
Bristol Myers Squibb's acquisition of Celgene was reported on August 31, 2026. Bristol Myers Squibb completed its acquisition of Celgene in 2019 for $74 billion, marking a significant expansion into the neuroscience space. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Celgene do?
Celgene is an American biopharmaceutical company that develops therapies for cancer and inflammatory disorders. It is notably recognized for its innovative medicines that help patients around the world. It is privately held, operating in Biotechnology, and is based in Ohio.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.